Outpatient gatifloxacin therapy and dysglycemia in older adults - Test2 - elhamkhani - TriplyDB

Outpatient gatifloxacin therapy and dysglycemia in older adults

Outpatient gatifloxacin therapy and dysglycemia in older adults

http://www.wikidata.org/entity/Q28299842

about

Canadian clinical practice guidelines for acute and chronic rhinosinusitis.Fluoroquinolones for treating typhoid and paratyphoid fever (enteric fever)Antituberculosis therapy for 2012 and beyond Epidemiology, Clinical Presentation, Laboratory Diagnosis, Antimicrobial Resistance, and Antimicrobial Management of Invasive Salmonella Infections Emergency department visits for antibiotic-associated adverse events A multi-center randomised controlled trial of gatifloxacin versus azithromycin for the treatment of uncomplicated typhoid fever in children and adults in Vietnam Therapeutic effect of a novel oxazolidinone, DA-7867, in BALB/c mice infected with Nocardia brasiliensis Cholinesterase inhibitors and hospitalization for bradycardia: a population-based study Proton pump inhibitors and hospitalization with hypomagnesemia: a population-based case-control study Road trauma in teenage male youth with childhood disruptive behavior disorders: a population based analysis Medication-induced diabetes mellitus.Bitter taste receptors influence glucose homeostasis Use of clarithromycin and adverse cardiovascular events among older patients receiving donepezil: a population-based, nested case-control study.An open randomized comparison of gatifloxacin versus cefixime for the treatment of uncomplicated enteric fever.Selective serotonin reuptake inhibitors and breast cancer mortality in women receiving tamoxifen: a population based cohort study Moxifloxacin versus ethambutol in the initial treatment of tuberculosis: a double-blind, randomised, controlled phase II trial Influences on the start, selection and duration of treatment with antibiotics in long-term care facilities.A multi-center randomized trial to assess the efficacy of gatifloxacin versus ciprofloxacin for the treatment of shigellosis in Vietnamese children Extended-release nifedipine and the risk of intestinal obstruction: a population-based study.Anti-infectives and the risk of severe hypoglycemia in users of glipizide or glyburide.Policy alternatives for treatments for rare diseases.Risks associated with the therapeutic use of fluoroquinolones.A study on drug safety monitoring program in India.The risk of hypotension following co-prescription of macrolide antibiotics and calcium-channel blockers A population-based study of the drug interaction between proton pump inhibitors and clopidogrel Fluoroquinolones and collagen associated severe adverse events: a longitudinal cohort study Four-month moxifloxacin-based regimens for drug-sensitive tuberculosis Gatifloxacin versus ofloxacin for the treatment of uncomplicated enteric fever in Nepal: an open-label, randomized, controlled trial Trimethoprim-sulfamethoxazole induced hyperkalaemia in elderly patients receiving spironolactone: nested case-control study.New regimens for reducing the duration of the treatment of drug-susceptible pulmonary tuberculosis.Safety of valproic acid in patients with chronic obstructive pulmonary disease: a population-based cohort study.Moxifloxacin in the treatment of skin and skin structure infections.Proton pump inhibitors and the risk of acute kidney injury in older patients: a population-based cohort study.Effects of funding policy changes and health warnings on the use of erythropoiesis-stimulating agents A population-based study of the drug interaction between clopidogrel and angiotensin converting enzyme inhibitors.Variability in antibiotic use at children's hospitals.Identifying geographical regions serviced by hospitals to assess laboratory-based outcomes.Crystal structure and stability of gyrase-fluoroquinolone cleaved complexes from Mycobacterium tuberculosis.A secure distributed logistic regression protocol for the detection of rare adverse drug events Correlation of different phenotypic drug susceptibility testing methods for four fluoroquinolones in Mycobacterium tuberculosis.

P2860

Q21245393-6B96661F-DD6C-4EB8-953C-E169F63B171B Q24236124-404AB556-FBA1-492A-B7DE-EC74A41C2513 Q26829101-BB644DFD-348F-453D-9EFC-07AEFF8A65E0 Q28084595-2A91526A-FE0A-49E6-A2F4-76AF9A8FBC29 Q28290501-66C80BAE-C0E8-460F-AD33-841589841ED1 Q28472731-9A1A8363-02D6-4955-9D87-8AD19C4EDC21 Q28473696-56053E97-2D77-41CB-B70B-F5AA8EC280E2 Q28476190-6844AABF-19EA-4096-8EA5-76B2309A15E0 Q28543390-B7B6F29B-50B7-4B13-8EF9-6CA6601D459D Q28748446-013BDB31-1F1F-4812-AF90-15B052AB5FD7 Q30276191-6C925434-1985-49E7-9537-4C15B96A4E55 Q30855188-305DA37D-18E4-4D39-8681-8A3B2524B48E Q33161031-5D938519-A921-4451-9CA0-46699FAF31D8 Q33288953-E3C2BD9F-CB6D-4E37-B5EC-E1F01537F161 Q33634928-DFAB0B5C-298E-4F23-96AF-2FB9830E6F7A Q33837706-C5954DC0-B3BE-4A0E-B7C3-22598DE977EC Q33848870-DF30E996-D002-42C1-B181-3DCC1731E2F1 Q33988931-3F86871B-A20D-4504-A9CE-7CCBE47142F0 Q33995817-B82D0C9B-4BE5-4E53-8F10-621AE02DEB50 Q34012336-CD6918D9-9E2E-499D-B90A-5818AEF292CB Q34334611-3AEA2077-8F76-4D17-A76D-CC1F05102F09 Q34343391-6470F188-1952-4BC6-95B9-ACE5D48103D1 Q34568354-6713E025-D864-4EAA-B5F1-E9F993A73699 Q34589838-10171262-D9FA-41F7-A5A6-CBB5DBD804EA Q34603772-A0873554-86F2-4874-9BE7-923109457CB0 Q34674473-BEB72194-DBBB-402B-AFDC-4B60DC827C1B Q34777926-32BDFC4B-3A97-4677-BFB3-B4FEE7BD3060 Q35055415-9CE4350E-CA35-4302-A6C7-FE4E40DEA8A9 Q35208686-F30C7B80-D534-48E9-A86D-59E8A17AD5A9 Q35676180-09508561-0F5E-40EF-A9BC-D2C8D287086F Q35835849-01E00238-1185-4417-8C60-203DC550A2FC Q35919259-57BEB662-984C-4FA6-9A07-AB10CA1C4444 Q36064989-64831DDA-08F2-4666-B6E3-1F73A12569FA Q36095172-9D7C329D-2B11-4B4D-AB9F-A867315D024F Q36125455-08E51413-A084-4FF4-A514-1E73A36E8F0A Q36366551-C7ADF77E-47C6-4E5F-8D93-4A088E34115F Q36545880-6C95F854-048E-43A5-9C99-3DD11275EDD7 Q36607637-FEC9CBC4-DB4A-4875-B334-AED545310733 Q36771100-B8E6B1A7-4E79-46AC-906A-D096C7099E75 Q36794791-8887739A-EEAE-460A-9F87-D6FBA89D534A

P2860

Outpatient gatifloxacin therapy and dysglycemia in older adults

http://www.wikidata.org/entity/Q28299842

description

2006 nî lūn-bûn

@nan

2006 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի մարտին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Outpatient gatifloxacin therapy and dysglycemia in older adults

@ast

Outpatient gatifloxacin therapy and dysglycemia in older adults

@en

Outpatient gatifloxacin therapy and dysglycemia in older adults

@nl

type

label

Outpatient gatifloxacin therapy and dysglycemia in older adults

@ast

Outpatient gatifloxacin therapy and dysglycemia in older adults

@en

Outpatient gatifloxacin therapy and dysglycemia in older adults

@nl

prefLabel

Outpatient gatifloxacin therapy and dysglycemia in older adults

@ast

Outpatient gatifloxacin therapy and dysglycemia in older adults

@en

Outpatient gatifloxacin therapy and dysglycemia in older adults

@nl

P1433

Q28299842-F756B62E-69BF-4196-B6AB-B4AE2C640E23

P1476

Q28299842-FFBA8EA8-9CC4-4139-8B3F-EEAD89F59AFB

P2093

Q28299842-0770D6C8-2905-4467-8C57-EE154EE162AB

Q28299842-6D3EFA2C-977B-44FC-99A1-415B5680B109

Q28299842-88246B2E-82BD-47FD-8D80-7BE40CAA6214

Q28299842-BA21BF33-09D5-448A-B30D-BB50BE2F0AF6

Q28299842-CA1AB092-72E7-489D-9B2F-1BA1792958DD

Q28299842-DFFAF3DF-5081-414A-BF84-619C53082D47

Q28299842-E9FB4185-5CBF-4B8E-A41D-3866156AD373

P304

Q28299842-99493D7D-31D0-40F1-BA62-7FF19BF62506

P31

Q28299842-D7CCCCF4-C941-4504-B3AE-5E37594CA92F

P356

Q28299842-5F3F90F3-C773-490F-A384-3F31EDDAA889

P407

Q28299842-737F8E93-125F-4365-98A3-6484EBA228F0

P433

Q28299842-190FD043-1C71-4F9F-A1A3-5227E6A6F7BA

P478

Q28299842-F40D9D55-9244-44DC-B743-A5E05E86A050

P50

Q28299842-2AF01CF4-1314-4B6A-B428-1BA08F3F60FE

Q28299842-8C36888F-8778-4062-ACF0-FD8B3155283E

P577

Q28299842-F6C2DCD1-216D-48CE-A9C9-94E6D7516FFB

P698

Q28299842-63D48353-E5BD-40D8-A721-3E6C186E188C

P356

P1433

The New England Journal of Medicine

P1476

Outpatient gatifloxacin therapy and dysglycemia in older adults

@en

P2093

Alexander Kopp

http://www.w3.org/2001/XMLSchema#string

Baiju R Shah

http://www.w3.org/2001/XMLSchema#string

Carmine Stumpo

http://www.w3.org/2001/XMLSchema#string

David N Juurlink

http://www.w3.org/2001/XMLSchema#string

Laura Y Park-Wyllie

http://www.w3.org/2001/XMLSchema#string

Linda Dresser

http://www.w3.org/2001/XMLSchema#string

Muhammad M Mamdani

http://www.w3.org/2001/XMLSchema#string

P304

1352-1361

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1056/NEJMOA055191

http://www.w3.org/2001/XMLSchema#string

P407

P433

13

http://www.w3.org/2001/XMLSchema#string

P478

354

http://www.w3.org/2001/XMLSchema#string

P50

Therese A. Stukel

P577

2006-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16510739

http://www.w3.org/2001/XMLSchema#string